.png?width=80&height=80&name=Evrima%20-%20Website%20Trial%20Icon%20(ADHD).png)
Mental Health (PTSD) Study
Take part in a new research study developing a tool to enhance the diagnostic process for PTSD.
This study is working to develop a diagnostic tool to support the identification of PTSD symptoms that could assist in supporting people suffering from symptoms of PTSD in a faster, more accessible way.
Eligibility
- Aged 18 and over
- Access to a smart device and iphone (model 13 as a minimum)
Location
Australia
Coeliac Disease (Daisy) Study
Take part in a new research study for a potential new treatment for Coeliac Disease
This study aims to assess the safety and efficacy of the investigational treatment. The trial is open for coeliac disease patients who have persistent symptoms/damage despite maintaining a Gluten Free Diet.
Eligibility
- 18 to 75 years of age
- Diagnosed with Coeliac disease
Location
QLD, NSW, and New Zealand
Dementia-related Agitation Study
Take part in a new research study for a potential new treatment for agitation associated with dementia.
This study aims to evaluate the effectiveness and safety of a potential new treatment for dementia-related agitation.
Eligibility
- Aged 50 - 90
- Current diagnosis of dementia
- Experiencing agitation/aggression episodes at least twice per week
- Have a caregiver or study partner who will be available to participate in the study
Location
VIC, NSW, and SA
Heart Health Study
We are currently looking for volunteers to take part in heart health studies.
This study aims to evaluate the safety and efficacy of an investigational drug that is aimed at reducing the plaque burden within the arteries.
Eligibility
- 40 to 79 years of age
- Diagnosis of Acute Coronary Syndrome
Location
SA
Allergy Study
Take part in a new research study for a potential new treatment for allergic diseases.
This study aims to evaluate the safety and tolerability of Exl-111 in developing a potential new treatment for various allergy response conditions.
Eligibility
- 18 to 55 years of age
- Suffer from mild or seasonal allergies
Location
SA
Skin Cancer Study
Help improve future treatment options for Basal Cell Carcinoma.
Skin cancer is the uncontrolled growth of abnormal skin cells, and with 2 in 3 Australians diagnosed in their lifetime—mostly due to UV exposure—it’s one of the country’s most serious and widespread health concerns.
Eligibility
- 18 to 85 years of age
- At least one histologically confirmed diagnosis or suspected lesion of nodular Basal Cell Carcinoma (nBCC)
Location
ACT and NSW
.png?width=80&height=80&name=SCLC%20ICON%20(2).png)
Expression of Interest:
Atherosclerosis Studies
Register your interest in new upcoming studies for Atherosclerosis
Eligibility
- Aged 45 to 80
Location
Australia
Need help with clinical trial information?
Search our Evrima help Centre for answers related to information about our active studies, information about managing your Evrilink account, and general clinical trial knowledge!
Read our FAQs